“Funding Will Be Used to Advance the Company’s Novel Monoclonal Antibody.”
For Immediate Release
September 1, 2020
“Funding Will Be Used to Advance the Company’s Novel Monoclonal Antibody.”
For Immediate Release
September 1, 2020